Search

everythinglearnresearchcommunity

for

Search:↓

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Edar signaling is crucial for controlling hair growth and regression.

Lichen planus is a skin condition that can resolve on its own, is linked to hepatitis C, and increases the risk of skin cancer.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Skin problems are common in lupus, often appearing first, with various types and treatments, and careful monitoring is important for diagnosis and management.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

Targeting androgen receptors could be a promising way to treat skin disorders with fewer side effects.

Nerves and chemicals in the body can affect hair growth and loss.

The document concludes that certain genetic mutations and dietary factors are involved in acne development, and treatments like isotretinoin and diet changes can help manage it.

Autoimmune diseases can cause hair loss, and early treatment is important to prevent permanent damage.

Some growth factors, while important for normal body functions, can cause diseases when not regulated properly.

Some drugs can cause skin reactions, which may improve when the drug is stopped, and rapid diagnosis and stopping the drug is crucial.

Cooling the scalp may prevent hair loss from chemotherapy, hair often grows back after treatment, and nail issues usually improve after stopping the drug.

Targeting the protein Caveolin-1 might help treat a type of scarring hair loss called Frontal Fibrosing Alopecia.

The document concludes that proper treatment and management of plaque psoriasis in adolescents can improve their quality of life.

The conference highlighted new dermatological treatments and emphasized early intervention and addressing conditions lacking evidence-based treatments.

Some people with primary cicatricial alopecia also have inflammatory bowel disease, suggesting a possible connection.

Apigenin, found in plants and vegetables, has many health benefits, including anti-inflammatory, antioxidant, and anticancer effects.

Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.

There is no standardized treatment for hidradenitis suppurativa, and individualized plans are needed.

Different treatments for Hidradenitis suppurativa range from antibiotics and hormonal therapies to surgery, depending on severity.

New treatments for COVID-19 show promise, but more effective antiviral drugs are needed.

Budesonide is not effective for maintaining remission in Crohn's disease beyond three months.

Mast cells likely promote skin scarring and fibrosis, but their exact role is still unclear.

Minoxidil can reduce functions related to androgen receptors.

Colchicine might help treat different skin diseases, but more research is needed to confirm its effectiveness and safe dosage.

New treatments like nanotechnology show promise in improving skin cancer therapy.

Using three different drugs together may better treat eye diseases like glaucoma and macular degeneration.

COVID-19 can cause hair loss in both severe and mild cases, often affecting women.